中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

ginsenoside f3/panax

链接已保存到剪贴板
页 1 从 24 结果
CROSS REFERENCE TO RELATED APPLICATIONS This application is a U.S. National Stage Application filed under 35 U.S.C. .sctn. 371 and claims priority to International Application No. PCT/KR/2015/004399, filed Apr. 30, 2015, which application claims priority to Korean Application No. 10-2014-0052728,
CROSS-REFERENCE TO RELATED APPLICATION This application claims the benefit of Korean Patent Application No. 10-2011-0070038, filed on Jul. 14, 2011 in the Korean Intellectual Property Office, the disclosure of which is incorporated herein by reference. TECHNICAL FIELD The present invention relates
CROSS-REFERENCE TO RELATED APPLICATIONS This application is a U.S. national phase under the provisions of 35 U.S.C. .sctn. 371 of International Patent Application No. PCT/KR15/08800 filed Aug. 24, 2015, which in turn claims priority of Korean Patent Application No. 10-2014-0109735 filed Aug. 22,
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/KR2016/011905 filed Oct. 21, 2016, claiming priority based on Korean Patent Application No. 10-2015-0147354 filed Oct. 22, 2015. TECHNICAL FIELD The present invention relates to a method
CROSS REFERENCE TO RELATED APPLICATIONS This application is a 35 U.S.C. .sctn.371 National Phase Entry Application from PCT/KR2011/003544, filed May 13, 2011, and designating the United States, which claims priority under 35 U.S.C. .sctn.119 to Korean Patent Application No. 10-2010-0045394 filed May
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/KR2016/011900 filed Oct. 21, 2016, claiming priority based on Korean Patent Application No. 10-2015-0147353 filed Oct. 22, 2015. TECHNICAL FIELD The present invention relates to a method
CROSS REFERENCE TO RELATED APPLICATIONS This application is a 35 U.S.C. .sctn. 371 National Phase Entry Application from PCT/KR2013/007852, filed on Aug. 30, 2013, and designating the United States, which is incorporated herein by reference in its entirety. TECHNICAL FIELD The present invention
This application claims priority upon Korean. Patent application Ser. No. KR 10-2005-00305 19 filed on Apr. 12, 2005, the contents of which are all herein incorporated by this reference in their entireties. All publications, patents, patent applications, databases and other references cited in this
FIELD OF THE INVENTION The present invention relates to a stable high ginsenoside-yielding callus line of Panax quinquefolium (American ginseng) developed from root explants and a process for the development of these callus lines. More particularly, the invented callus line has a distinct
CROSS REFERENCE TO RELATED APPLICATION This is a National Stage of International Application No. PCT/KR2009/006311, filed Oct. 30, 2009, which claims the benefit of Application No. 10-2008-0109038, filed in Korea on Nov. 4, 2008, the disclosures of which Applications are incorporated by reference
TECHNICAL FIELD The invention belongs to the field of medicines, and relates to a medicine or health food for treating human cytomegalovirus infection, particularly to application of ginseng (a traditional Chinese medicine) extracts and derivatives thereof in medicines or health foods for treating

Vaccine adjuvants comprising ginseng plant extract and added aluminum salt

只有注册用户可以翻译文章
登陆注册
TECHNICAL FIELD The present invention relates to a new group of adjuvants capable of enhancing the immunogenic effect of antigens used in immunization of mammals. The invention also relates to a method of producing am immunogenic composition comprising the adjuvant according to the

Method for processing ginseng and the uses of extract of processed ginseng

只有注册用户可以翻译文章
登陆注册
TECHNICAL FIELD The present invention relates to a method for processing ginseng and the uses of the extract of the processed ginseng. More particularly, the present invention relates to extract of processed ginseng or extract of saponin fraction of the processed ginseng, which improves the ratio of

Method for producing cultured root of purple ginseng

只有注册用户可以翻译文章
登陆注册
CROSS-REFERENCE TO RELATED APPLICATION This application claims the benefit of Korean Patent Application No. 10-2011-0020355, filed on Mar. 8, 2011 in the Korean Intellectual Property Office, Korean Patent Application No. 10-2011-0030577, filed on Apr. 4, 2011 in the Korean Intellectual Property

Cultivation method of coffee tree by red ginseng powdered extract

只有注册用户可以翻译文章
登陆注册
The present application is based on, and claims priority from the Korean Patent Application Number 10-2016-0006630 filed on Jan. 19, 2016, the entire contents of which are incorporated by reference herein in their entirety. TECHNICAL FIELD The teachings in accordance with the exemplary embodiments
加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge